The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A Prospective Study of Age Trends in Cervical Human Papillomavirus Acquisition and Persistence in Guanacaste, Costa Rica
Abstract
BACKGROUND: Cross-sectional human papillomavirus (HPV) DNA prevalence peaks at young ages, reflecting sexual acquisition and typically rapid clearance. In some populations, HPV prevalence demonstrates a second peak in older women. Longitudinal data may help to explain this second peak. METHODS: We followed a population-based cohort of 7237 women in Guanacaste, Costa Rica, in which we had previously observed a second peak in the baseline HPV prevalence in older women. We tested for >40 HPV types by polymerase chain reaction. We analyzed age-specific patterns of acquisition and persistence 5-7 years after enrollment for individual HPV types. RESULTS: At enrollment and follow-up, cross-sectional data revealed U-shaped age-specific HPV prevalence curves for virtually every type, with higher prevalences in the younger and older women than in the middle-aged women. Prospectively, acquisition of types decreased significantly as women aged (PTrend<.05, for both), with the highest peak in young women and a secondary minor peak in older women. Type-specific persistence of HPV increased with age (PTrend<.0001). Overall, HPV acquisition predominated at younger ages, whereas persistent infections gradually became more prominent with age (PTrend<.0001). CONCLUSIONS: Newly apparent infections decreased, whereas persistence increased, with age; this latter tendency supports the utility of HPV screening in older women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Self-citationNATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
Saslow, D., Runowicz, C. D., Solomon, D., Moscicki, A.-B., Smith, R. A., Eyre, H. J., & Cohen, C. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.342 · Cited by 927
Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia
Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R., & Romney, S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.18.1365 · Cited by 803
Self-citationNobbenhuis, M. A., Walboomers, J. M., Helmerhorst, T. J., Rozendaal, L., Remmink, A. J., Risse, E. K., van der Linden, H. C., Voorhorst, F. J., Kenemans, P., & Meijer, C. J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12490-x · Cited by 685
Franco, E. L., Villa, L. L., Sobrinho, J. P., Prado, J. M., Rousseau, M., Désy, M., & Rohan, T. E. (1999) · The Journal of Infectious Diseases · doi:10.1086/315086 · Cited by 657
Persistent Human Papillomavirus Infection as a Predictor of Cervical Intraepithelial Neoplasia
Schlecht, N. F. (2001) · JAMA · doi:10.1001/jama.286.24.3106 · Cited by 590
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Hutchinson, M., Morales, J., Balmaceda, I., Greenberg, M. D., Alfaro, M., Burk, R. D., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.6.464 · Cited by 586
Self-citationWright, T. C., Schiffman, M., Solomon, D., Cox, J. T., Garcia, F., Goldie, S., Hatch, K., Noller, K. L., Roach, N., Runowicz, C., et al. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000109426.82624.f8 · Cited by 499
Self-citationPCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems
Qu, W., Jiang, G., Cruz, Y., Chang, C. J., Ho, G. Y., Klein, R. S., & Burk, R. D. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.6.1304-1310.1997 · Cited by 463
Self-citation
Cited by
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Self-citationHuman papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Bruni, L., Diaz, M., Castellsagué, X., Ferrer, E., Bosch, F. X., & de Sanjosé, S. (2010) · The Journal of Infectious Diseases · doi:10.1086/657321 · Cited by 1,641
Human papillomavirus and cervical cancer
Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60022-7 · Cited by 1,171
Prevalence of Oral HPV Infection in the United States, 2009-2010
Gillison, M. L., Broutian, T., Pickard, R. K. L., Tong, Z.-Y., Xiao, W., Kahle, L., Graubard, B. I., & Chaturvedi, A. K. (2012) · JAMA · doi:10.1001/jama.2012.101 · Cited by 1,064
Khan, M. J., Castle, P. E., Lorincz, A. T., Wacholder, S., Sherman, M., Scott, D. R., Rush, B. B., Glass, A. G., & Schiffman, M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji187 · Cited by 1,053
Self-citationThe natural history of cervical HPV infection: unresolved issues
Woodman, C. B. J., Collins, S. I., & Young, L. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2050 · Cited by 1,033
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
Bosch, F. X., Burchell, A. N., Schiffman, M., Giuliano, A. R., de Sanjose, S., Bruni, L., Tortolero-Luna, G., Kjaer, S. K., & Muñoz, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.064 · Cited by 842
Self-citationThe epidemiology of genital human papillomavirus infection
Trottier, H., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.054 · Cited by 686
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
Arbyn, M., Sasieni, P., Meijer, C. J. L. M., Clavel, C., Koliopoulos, G., & Dillner, J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.117 · Cited by 539
Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study
Giuliano, A. R., Lee, J.-H., Fulp, W., Villa, L. L., Lazcano, E., Papenfuss, M. R., Abrahamsen, M., Salmeron, J., Anic, G. M., Rollison, D. E., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62342-2 · Cited by 500
Model for Assessing Human Papillomavirus Vaccination Strategies
Elbasha, E. H., Dasbach, E. J., & Insinga, R. P. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060438 · Cited by 491
Chapter 5: Updating the natural history of HPV and anogenital cancer
Moscicki, A.-B., Schiffman, M., Kjaer, S., & Villa, L. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.018 · Cited by 478
Self-citationVariations in the age‐specific curves of human papillomavirus prevalence in women worldwide
Franceschi, S., Herrero, R., Clifford, G. M., Snijders, P. J. F., Arslan, A., Anh, P. T. H., Bosch, F. X., Ferreccio, C., Hieu, N. T., Lazcano‐Ponce, E., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22241 · Cited by 415
Self-citationHuman papillomavirus types among women infected with HIV: a meta-analysis
Clifford, G. M., Gonçalves, M. A. G., & Franceschi, S. (2006) · AIDS · doi:10.1097/01.aids.0000253361.63578.14 · Cited by 395
Rodriguez, A. C., Schiffman, M., Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Solomon, D., Guillen, D., Alfaro, M., Morales, J., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq001 · Cited by 383
Self-citationHerrero, R., Castle, P. E., Schiffman, M., Bratti, M. C., Hildesheim, A., Morales, J., Alfaro, M., Sherman, M. E., Wacholder, S., Chen, S., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428850 · Cited by 377
Self-citationHuman papillomavirus and HPV vaccines: a review
Cutts, F. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.038414 · Cited by 370
Tota, J. E., Chevarie-Davis, M., Richardson, L. A., deVries, M., & Franco, E. L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.08.017 · Cited by 261
Epidemiology of Mucosal Human Papillomavirus Infection and Associated Diseases
Trottier, H., & Burchell, A. N. (2009) · Public Health Genomics · doi:10.1159/000214920 · Cited by 156
Ogilvie, G. S., Krajden, M., van Niekerk, D., Smith, L. W., Cook, D., Ceballos, K., Lee, M., Gentile, L., Gondara, L., Elwood‐Martin, R., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30454 · Cited by 101
Datta, P., Bhatla, N., Pandey, R. M., Dar, L., Patro, A. R., Vasisht, S., Kriplani, A., & Singh, N. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.3.1019 · Cited by 31
Rositch, A. F., Silver, M. I., Burke, A., Viscidi, R., Chang, K., Duke, C. M. P., Shen, W., & Gravitt, P. E. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3182503402 · Cited by 27
Metadata
- Authors
- Castle, P. E., Schiffman, M., Herrero, R., Hildesheim, A., Rodriguez, A. C., Bratti, M. C., Sherman, M. E., Wacholder, S., Tarone, R., & Burk, R. D.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06
- Volume
- 191
- Issue
- 11
- Pages
- 1808-1816
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2153328588
- Cited by
- 403
- References
- 30
- FWCI
- 20.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.